Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision label updated from v3.6.4 to v3.6.5. This indicates a newer version of the page was published, without changes to the displayed clinical trial information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new version of the page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision tag changes from v3.6.2 to v3.6.3, reflecting a small template update. It does not alter the study details or how information is presented to users.SummaryDifference0.1%

- Check59 days agoChange DetectedA new page revision label, v3.6.2, has been added. The previous revision label, v3.6.0, was removed, indicating an update to the page content.SummaryDifference0.1%

- Check73 days agoChange DetectedA recruitment status notice 'No longer looking for participants' was added, indicating the study is not enrolling. New help and navigation items—'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'—were added, and the 'Intervention / Treatment' heading was reformatted to 'Intervention/Treatment' while the old 'Revision: v3.5.5' note was removed in favor of 'Revision: v3.6.0'.SummaryDifference0.4%

- Check80 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the study record display.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.